IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue
IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue
Read moreThu, 31st Jan 2013 14:33
IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue
Read moreScancell To Start Clinical Trial For Cancer Treatment In 2021
Read more(Sharecast News) - Cancer immunotherapy developer Scancell Holdings noted the publication of its manuscript in Cancer Research, a journal of the American Association of Cancer Research (AACR) on Friday, titled 'Engineering the human Fc-region enables direct cell killing by cancer glycan-targeting antibodies without the need for immune effector cells or complement'.
Read more(Sharecast News) - Scancell revealed on Tuesday that non-executive director Martin Diggle had sold 1.5m ordinary shares in the AIM-listed biotechnology firm.
Read moreUK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price
Read moreScancell Rises On Launch Of Covid-19 Vaccine Research Programme
Read moreUK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost
Read more(Sharecast News) - Cancer immunotherapy developer Scancell announced on Monday that its investigational new drug (IND) application to the United States Food and Drug Administration (FDA) for 'SCIB1' has been approved.
Read moreScancell Gets US FDA Approval For SCIB1 Drug Application
Read moreScancell Interim Loss Narrows, Progresses On Product Pipeline
Read moreScancell Teams To Evaluate Its Antibody Platform For Cancer Treatment
Read moreDIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 3 Million Shares
Read more(Sharecast News) - Scancell Holdings on Monday signed a collaboration and non-exclusive research agreement with an unnamed Chinese biotechnology firm.
Read moreScancell Shares Jump As It Secures First Deal In China For AvidiMab
Read moreOxford Technology VCTs Report Mixed Third-Quarter Performances
Read more